Treating menopause—MHT and beyond
SR Davis, RJ Baber - Nature Reviews Endocrinology, 2022 - nature.com
Every woman who lives past midlife will experience menopause, which, by definition, is
complete cessation of ovarian function. This process might occur spontaneously (natural …
complete cessation of ovarian function. This process might occur spontaneously (natural …
[HTML][HTML] Alzheimer's disease: risk factors and potentially protective measures
MVF Silva, CMG Loures, LCV Alves… - Journal of biomedical …, 2019 - Springer
Alzheimer's disease (AD) is the most common type of dementia and typically manifests
through a progressive loss of episodic memory and cognitive function, subsequently causing …
through a progressive loss of episodic memory and cognitive function, subsequently causing …
The 2022 hormone therapy position statement of the North American Menopause Society
SS Faubion, CJ Crandall, L Davis… - …, 2022 - ingentaconnect.com
“The 2022 Hormone Therapy Position Statement of The North American Menopause
Society”(NAMS) updates “The 2017 Hormone Therapy Position Statement of The North …
Society”(NAMS) updates “The 2017 Hormone Therapy Position Statement of The North …
[HTML][HTML] X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women
Although women experience significantly higher tau burden and increased risk for
Alzheimer's disease (AD) than men, the underlying mechanism for this vulnerability has not …
Alzheimer's disease (AD) than men, the underlying mechanism for this vulnerability has not …
Understanding the impact of sex and gender in Alzheimer's disease: a call to action
RA Nebel, NT Aggarwal, LL Barnes, A Gallagher… - Alzheimer's & …, 2018 - Elsevier
Introduction Precision medicine methodologies and approaches have advanced our
understanding of the clinical presentation, development, progression, and management of …
understanding of the clinical presentation, development, progression, and management of …
Alzheimer's pathogenic mechanisms and underlying sex difference
AD is a neurodegenerative disease, and its frequency is often reported to be higher for
women than men: almost two-thirds of patients with AD are women. One prevailing view is …
women than men: almost two-thirds of patients with AD are women. One prevailing view is …
Defeating Alzheimer's disease and other dementias: a priority for European science and society
Executive summary Alzheimer's disease (AD) is the leading cause of dementia, and
because the primary risk factor for AD is old age, the prevalence of the disease is increasing …
because the primary risk factor for AD is old age, the prevalence of the disease is increasing …
[HTML][HTML] Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European …
Background The risk of dementia is higher in women than men. The metabolic
consequences of estrogen decline during menopause accelerate neuropathology in …
consequences of estrogen decline during menopause accelerate neuropathology in …
Management of menopause: a view towards prevention
Women spend approximately one-third of their lives with menopause, which occurs around
50 years of age. It is now appreciated that several important metabolic and cardiovascular …
50 years of age. It is now appreciated that several important metabolic and cardiovascular …
[HTML][HTML] Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women's Health Initiative randomized trials
JAE Manson, AK Aragaki, JE Rossouw, GL Anderson… - Jama, 2017 - jamanetwork.com
Importance Health outcomes from the Women's Health Initiative Estrogen Plus Progestin
and Estrogen-Alone Trials have been reported, but previous publications have generally not …
and Estrogen-Alone Trials have been reported, but previous publications have generally not …